Multi-task learning-based feature selection and classification models for glioblastoma and solitary brain metastases.

Abstract

PurposeTo investigate the diagnostic performance of feature selection via a multi-task learning model in distinguishing primary glioblastoma from solitary brain metastases.MethodThe study involved 187 patients diagnosed at Xiangya Hospital, Yunnan Provincial Cancer Hospital, and Southern Cancer Hospital between January 2010 and December 2018. Radiomic features were extracted from conventional magnetic resonance imaging including T1-weighted, T2-weighted, and contrast-enhanced T1-weighted sequences. We proposed a new multi-task learning model using these three sequences as three tasks. Multi-series fusion was performed to complement the information from different dimensions in order to enhance model robustness. Logical loss was used in the model as the data-fitting item, and the feature weights were expressed in the logical loss space as the sum of shared weights and private weights to select the common features of each task and the characteristics having an essential impact on a single task. A diagnostic model was constructed as a feature selection method as well as a classification method. We calculated accuracy, recall, precision, and area under the curve (AUC) and compared the performance of our new multi-task model with traditional diagnostic model performance.ResultsA diagnostic model combining the support vector machine algorithm as a classification algorithm and our model as a feature selection method had an average AUC of 0.993 in the training set, with AUC, accuracy, precision, and recall rates respectively of 0.992, 0.920, 0.969, and 0.871 in the test set. The diagnostic model built on our multi-task model alone, in the training set, had an average AUC of 0.987, and in the test set, the AUC, accuracy, precision, and recall rates were 0.984, 0.895, 0.954, and 0.838.ConclusionIt is feasible to implement the multi-task learning model developed in our study using logistic regression to differentiate between glioblastoma and solitary brain metastases.